KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Non-Current Debt (2016 - 2025)

Merck (MRK) has disclosed Non-Current Debt for 17 consecutive years, with $46.8 billion as the latest value for Q4 2025.

  • Quarterly Non-Current Debt rose 35.66% to $46.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $46.8 billion through Dec 2025, up 35.66% year-over-year, with the annual reading at $46.8 billion for FY2025, 35.66% up from the prior year.
  • Non-Current Debt for Q4 2025 was $46.8 billion at Merck, up from $40.0 billion in the prior quarter.
  • The five-year high for Non-Current Debt was $46.8 billion in Q4 2025, with the low at $22.9 billion in Q3 2021.
  • Average Non-Current Debt over 5 years is $31.9 billion, with a median of $32.3 billion recorded in 2024.
  • The sharpest move saw Non-Current Debt fell 12.97% in 2021, then soared 35.66% in 2025.
  • Over 5 years, Non-Current Debt stood at $30.7 billion in 2021, then fell by 6.34% to $28.7 billion in 2022, then grew by 17.18% to $33.7 billion in 2023, then rose by 2.31% to $34.5 billion in 2024, then soared by 35.66% to $46.8 billion in 2025.
  • According to Business Quant data, Non-Current Debt over the past three periods came in at $46.8 billion, $40.0 billion, and $34.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.